PL3755684T3 - Pochodne alkoholowe jako substancje otwierające kanał potasowy kv7 - Google Patents

Pochodne alkoholowe jako substancje otwierające kanał potasowy kv7

Info

Publication number
PL3755684T3
PL3755684T3 PL18708346.4T PL18708346T PL3755684T3 PL 3755684 T3 PL3755684 T3 PL 3755684T3 PL 18708346 T PL18708346 T PL 18708346T PL 3755684 T3 PL3755684 T3 PL 3755684T3
Authority
PL
Poland
Prior art keywords
potassium channel
alcohol derivatives
channel openers
openers
derivatives
Prior art date
Application number
PL18708346.4T
Other languages
English (en)
Inventor
Mario Rottländer
Anette Graven Sams
Xiaofang Wang
Debasis DAS
Jian Hong
Shu Hui Chen
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of PL3755684T3 publication Critical patent/PL3755684T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/26Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
PL18708346.4T 2018-02-20 2018-02-20 Pochodne alkoholowe jako substancje otwierające kanał potasowy kv7 PL3755684T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18708346.4A EP3755684B1 (en) 2018-02-20 2018-02-20 Alcohol derivatives as kv7 potassium channel openers
PCT/EP2018/054057 WO2019161877A1 (en) 2018-02-20 2018-02-20 Alcohol derivatives as kv7 potassium channel openers

Publications (1)

Publication Number Publication Date
PL3755684T3 true PL3755684T3 (pl) 2023-11-06

Family

ID=61557232

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18708346.4T PL3755684T3 (pl) 2018-02-20 2018-02-20 Pochodne alkoholowe jako substancje otwierające kanał potasowy kv7

Country Status (11)

Country Link
EP (2) EP4241843A3 (pl)
JP (1) JP7121144B2 (pl)
CN (2) CN116589375A (pl)
ES (1) ES2951656T3 (pl)
HR (1) HRP20230808T1 (pl)
HU (1) HUE063567T2 (pl)
MA (1) MA51881B1 (pl)
MD (1) MD3755684T2 (pl)
PL (1) PL3755684T3 (pl)
RS (1) RS64479B1 (pl)
WO (1) WO2019161877A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10590067B2 (en) 2018-02-20 2020-03-17 H. Lundbeck A/S Alcohol derivatives of carboxamides as Kv7 potassium channel openers
CR20220028A (es) * 2019-08-02 2022-03-02 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7
AR119521A1 (es) 2019-08-02 2021-12-22 H Lundbeck As DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7
CN114206328A (zh) * 2019-08-02 2022-03-18 H.隆德贝克有限公司 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物
CN115461327A (zh) 2020-04-29 2022-12-09 爱杜西亚药品有限公司 螺脲衍生物
EP4172140A1 (en) 2020-06-25 2023-05-03 Idorsia Pharmaceuticals Ltd Cyclobutyl-urea derivatives
WO2024121779A1 (en) 2022-12-09 2024-06-13 Pfizer Inc. Papain-like protease (plpro) inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152202A0 (en) 2000-05-26 2003-05-29 Bristol Myers Squibb Co Human kcnq5 polypeptide and pharmaceutical compositions containing the same
WO2001096540A2 (en) 2000-06-11 2001-12-20 Dupont Pharmaceuticals Company Hepatitis c protease exosite for inhibitor design
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
KR20080096659A (ko) 2006-02-07 2008-10-31 하. 룬트벡 아크티에 셀스카브 정신분열증 증상의 치료 또는 감소를 위한 kcnq개방제의 용도
WO2007104717A1 (en) * 2006-03-15 2007-09-20 Neurosearch A/S Quinazolinones and their use as potassium channels activators
MX2010001171A (es) 2007-08-01 2010-03-01 Lundbeck & Co As H Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sistema dopaminergico.
TW201024286A (en) * 2008-11-27 2010-07-01 Neurosearch As Novel compounds
WO2014090731A1 (en) 2012-12-10 2014-06-19 H. Lundbeck A/S New positive allosteric modulators of nicotinic acetylcholine receptor
WO2014145852A2 (en) * 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
DK3572405T3 (da) * 2014-09-12 2023-10-16 Biohaven Therapeutics Ltd Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer
JP2017095366A (ja) 2015-11-18 2017-06-01 持田製薬株式会社 新規ビアリールアミド誘導体
CN105663136A (zh) * 2016-01-15 2016-06-15 河北中医学院 法舒地尔作为制备选择性Kv7离子通道激活剂药物的应用

Also Published As

Publication number Publication date
JP2021519814A (ja) 2021-08-12
BR112019021960A2 (pt) 2020-08-25
EP4241843A3 (en) 2023-09-27
JP7121144B2 (ja) 2022-08-17
CN111727182B (zh) 2023-05-26
EP4241843A2 (en) 2023-09-13
ES2951656T3 (es) 2023-10-24
WO2019161877A1 (en) 2019-08-29
HUE063567T2 (hu) 2024-01-28
CN111727182A (zh) 2020-09-29
MD3755684T2 (ro) 2023-11-30
EP3755684B1 (en) 2023-07-12
MA51881B1 (fr) 2023-08-31
CN116589375A (zh) 2023-08-15
HRP20230808T1 (hr) 2023-11-10
RS64479B1 (sr) 2023-09-29
MA51881A (fr) 2020-12-30
EP3755684A1 (en) 2020-12-30
EP3755684C0 (en) 2023-07-12

Similar Documents

Publication Publication Date Title
PL3755684T3 (pl) Pochodne alkoholowe jako substancje otwierające kanał potasowy kv7
AU2015212265A1 (en) Anti-HER2 antibody-drug conjugate
EP3245227A4 (en) Multispecific immunomodulatory antigen-binding constructs
EP3130608A4 (en) (anti-her2 antibody)-drug conjugate
EP3748205A4 (en) SLIDING PARTS
EP3677802A4 (en) SLIDING PART
EP3590545A4 (en) COMPOSITION TO BE INJECTED INTO THE SKIN
EP3773721A4 (en) STABLE ANTI-CD79B IMMUNOCONJUGATE FORMULATIONS
IL268931B (en) New compounds for use as potassium channel openers
EP3653914A4 (en) SLIDING PARTS
EP3318245A4 (en) COSMETIC COMPOSITION BLOCKING UV
EP3294772A4 (en) BINDING CONSTRUCTS TO HER2 TARGETING ANTIGEN
EP3422924A4 (en) ENDOSCOPE WITH COMMON WORKING CHANNEL
EP3607832A4 (en) FLAVOR ENHANCER
EP4005420A4 (en) LOW TEMPERATURE SMOKE SET
KR101881983B1 (ko) 새로운 유형의 kcnq 칼륨 통로 작동제, 그의 제조 방법 및 그의 용도
EP3468523A4 (en) HYDRATING LIP BALM COMPOSITION
EP3476062A4 (en) TIME DELAY SETTING COMMUNICATION
IL282639A (en) Aryl sulfonyl pyrrole carboxamide derivatives as KV3 potassium station-activators
EP3375782A4 (en) SODIUM CHANNEL BLOCKER
EP3872375A4 (en) SLIDING ELEMENT
EP3825442A4 (en) SLIDING ELEMENT
EP3566796A4 (en) SLIDING NOZZLE
IL290193A (en) Alcohol derivatives as kv7 potassium channel openers
EP3765321A4 (en) SLIDING SUN VISOR